Refractory Lymphomas Recruiting Phase 2 Trials for Chloride ion (DB14547)

Also known as: Refractory Lymphoma

IndicationStatusPhase
DBCOND0042145 (Refractory Lymphomas)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03418038Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or Clonal Cytopenia of Undetermined SignificanceTreatment